Bayer's shares comeback?

P/E: 25
Consensus Forward P/E: 14
Dividend Yield 2.46%
Average target price 118 (28 analysts)

The company's pending acquisition presents unique risks to investors. Hence, share price was plummeting over months. Price bottom was reached after positive news about the Monsanto deal was going to be spread, market strong bearish sentiment (e.g trade war fears) waned and smart money started to transfer money from tech stocks to big solid growth companies like Bayer.

For investors in Big Pharma this might be an interesting company (conglomerate) with several major segments that are a medical device business, a seed business and animal health.

I have my problems with the company's future and diversity, but investors might think differently on it.

Trade closed: stop reached: Weak market pushed Bayer shares back below 100. I sold with a small profit and closed position.
EN English
EN English (UK)
EN English (IN)
DE Deutsch
FR Français
ES Español
IT Italiano
PL Polski
SV Svenska
TR Türkçe
RU Русский
PT Português
ID Bahasa Indonesia
MS Bahasa Melayu
TH ภาษาไทย
VI Tiếng Việt
JA 日本語
KO 한국어
ZH 简体中文
ZH 繁體中文
AR العربية
HE עברית
Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out